The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options
Open accessAbstract
Aldose reductase (AR) is widely expressed aldehyde-metabolizing enzyme. The reduction of glucose by the AR-catalyzed polyol pathway has been linked to the development of secondary diabetic complications. Although treatment with AR inhibitors has been shown to prevent tissue injury in animal models of diabetes, the clinical efficacy of these drugs remains to be established. Recent studies suggest that glucose may be an incidental substrate of AR, which appears to be more adept in catalyzing the reduction of a wide range of aldehydes generated from lipid peroxidation. Moreover, inhibition of the enzyme has been shown to increase inflammation-induced vascular oxidative stress and prevent myocardial protection associated with the late phase of ischemic preconditioning. On the basis of these studies, several investigators have ascribed an important antioxidant role to the enzyme. Additionally, ongoing work indicates that AR is a critical component of intracellular signaling, and inhibition of the enzyme prevents high glucose-, cytokine-, or growth factor-induced activation of protein kinase C and nuclear factor-κ-binding protein. Thus, treatment with AR inhibitors prevents vascular smooth muscle cell growth and endothelial cell apoptosis in culture and inflammation and restenosis in vivo. Additional studies indicate that the antioxidant and signaling roles of AR are interlinked and that AR regulates protein kinase C and nuclear factor-κB via redox-sensitive mechanisms. These data underscore the need for reevaluating anti-AR interventions for the treatment of diabetic complications. Potentially, the development of newer drugs that selectively inhibit ARmediated glucose metabolism and signaling, without affecting aldehyde detoxification, may be useful in preventing inflammation associated with the development of diabetic complications, particularly micro- and macrovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells
Spycher, S. E., Tabataba‐Vakili, S., O’Donnell, V. B., Palomba, L., & Azzi, A. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039961 · Cited by 144
RetractedNitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Hyperglycemic Pseudohypoxia and Diabetic Complications
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Den Enden, M. V., Kilo, C., & Tilton, R. G. (1993) · Diabetes · doi:10.2337/diab.42.6.801 · Cited by 1,105
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
BASTA, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.001 · Cited by 999
Yan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513
Wilson, D. K., Bohren, K. M., Gabbay, K. H., & Quiocho, F. A. (1992) · Science · doi:10.1126/science.1621098 · Cited by 432
Formation of Polyols by the Lens of the Rat with ‘Sugar’ Cataract
VAN HEYNINGEN, R. (1959) · Nature · doi:10.1038/184194b0 · Cited by 431
Molecular basis of osmotic regulation
Burg, M. B. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.6.f983 · Cited by 368
Lee, A. Y., Chung, S. K., & Chung, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2780 · Cited by 310
Asnaghi, V., Gerhardinger, C., Hoehn, T., Adeboje, A., & Lorenzi, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.506 · Cited by 279
Derubertis, F. R., & Craven, P. A. (1994) · Diabetes · doi:10.2337/diabetes.43.1.1 · Cited by 275
Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension
Vaziri, N. D. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200401000-00013 · Cited by 253
Aldose reductase in diabetic complications of the eye
Kinoshita, J. H., Fukushi, S., Kador, P., & Merola, L. O. (1979) · Metabolism · doi:10.1016/0026-0495(79)90057-x · Cited by 238
Srivastava, S., Chandra, A., Wang, L.-F., Seifert, W. E., DaGue, B. B., Ansari, N. H., Srivastava, S. K., & Bhatnagar, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10893 · Cited by 222
Self-citationO'CONNOR, T., IRELAND, L. S., HARRISON, D. J., & HAYES, J. D. (1999) · Biochemical Journal · doi:10.1042/bj3430487 · Cited by 217
Derubertis, F. R., & Craven, P. A. (1994) · Diabetes · doi:10.2337/diab.43.1.1 · Cited by 212
Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis
Rittner, H. L., Hafner, V., Klimiuk, P. A., Szweda, L. I., Goronzy, J. J., & Weyand, C. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4711 · Cited by 205
Aldose Reductase Inhibitors: The End of an Era or the Need for Different Trial Designs?
Pfeifer, M. A., Schumer, M. P., & Gelber, D. A. (1997) · Diabetes · doi:10.2337/diab.46.2.s82 · Cited by 194
Varma, S. D., & Kinoshita, J. H. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90457-3 · Cited by 192
Diabetic Cataracts and Flavonoids
Varma, S. D., Mizuno, A., & Kinoshita, J. H. (1977) · Science · doi:10.1126/science.401544 · Cited by 189
Le mécanisme de la transformation de glucose en fructose par les vésicules séminales
Hers, H. G. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90247-5 · Cited by 186
Yagihashi, S. (2001) · Brain · doi:10.1093/brain/124.12.2448 · Cited by 174
Structural and Kinetic Determinants of Aldehyde Reduction by Aldose Reductase
Srivastava, S., Watowich, S. J., Petrash, J. M., Srivastava, S. K., & Bhatnagar, A. (1999) · Biochemistry · doi:10.1021/bi981794l · Cited by 173
Self-citationRamana, K. V., Friedrich, B., Srivastava, S., Bhatnagar, A., & Srivastava, S. K. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2910 · Cited by 170
Self-citationDirect Measurement of Polyol Pathway Activity in the Ocular Lens
González, R. G., Barnett, P., Aguayo, J., Cheng, H.-M., & Chylack, L. T. (1984) · Diabetes · doi:10.2337/diab.33.2.196 · Cited by 165
Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat.
Wilson, D. K., Tarle, I., Petrash, J. M., & Quiocho, F. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9847 · Cited by 162
Aldose reductase: Congenial and injurious profiles of an enigmatic enzyme
Bhatnagar, A., & Srivastava, S. K. (1992) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(92)90055-4 · Cited by 162
Self-citationAldose Reductase in Diabetic Cataracts
Kinoshita, J. H. (1981) · JAMA · doi:10.1001/jama.1981.03320030049032 · Cited by 150
Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1737 · Cited by 141
Satoh, A., Gukovskaya, A. S., Nieto, J. M., Cheng, J. H., Gukovsky, I., Reeve, J. R., Shimosegawa, T., & Pandol, S. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00087.2004 · Cited by 140
Aldose Reductase Inhibition Protects Diabetic and Nondiabetic Rat Hearts from Ischemic Injury
Ramasamy, R., Oates, P. J., & Schaefer, S. (1997) · Diabetes · doi:10.2337/diab.46.2.292 · Cited by 137
Aldose Reductase Is an Obligatory Mediator of the Late Phase of Ischemic Preconditioning
Shinmura, K., Bolli, R., Liu, S.-Q., Tang, X., Kodani, E., Xuan, Y., Srivastava, S., & Bhatnagar, A. (2002) · Circulation Research · doi:10.1161/01.res.0000029970.97247.57 · Cited by 135
Self-citationEnzymology and Molecular Biology of Carbonyl Metabolism 6
Weiner, H., Lindahl, R., Crabb, D. W., & Flynn, T. G. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5871-2 · Cited by 135
Use of Antioxidant Nutrients in the Prevention and Treatment of Type 2 Diabetes
Ruhe, R. C., & McDonald, R. B. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719169 · Cited by 134
Central role for aldose reductase pathway in myocardial ischemic injury
Hwang, Y. C., Kaneko, M., Bakr, S. A., Liao, H., Lu, Y., Lewis, E., Yan, S.-D., Ii, S., Itakura, M., Liu, R., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1400com · Cited by 129
Petrash, J. M., Harter, T. M., Devine, C. S., Olins, P. O., Bhatnagar, A., Liu, S.-Q., & Sk, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35839-3 · Cited by 122
Self-citationPrice, S. A., Agthong, S., Middlemas, A., & Tomlinson, D. R. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1851 · Cited by 122
Tarle, I., Borhani, D. W., Wilson, D. K., Quiocho, F. A., & Petrash, J. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74444-5 · Cited by 121
Srivastava, S., Dixit, B. L., Cai, J., Sharma, S., Hurst, H. E., Bhatnagar, A., & Sk, S. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00351-8 · Cited by 118
Self-citationMolecular Mechanisms of In-Stent Restenosis and Approach to Therapy with Eluting Stents
Indolfi, C., Mongiardo, A., Antonio, C., & Torella, D. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(03)00038-0 · Cited by 116
Jagt, D. L. V., Hassebrook, R. K., Hunsaker, L. A., Brown, W. M., & Royer, R. E. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00298-2 · Cited by 107
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors
Frank, R. N. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01321-1 · Cited by 104
Aldose reductase activation is a key component of myocardial response to ischemia
Hwang, Y. C., Sato, S., Tsai, J.-Y., Yan, S.-D., Bakr, S. A., Zhang, H., Oates, P. J., & Ramasamy, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0368fje · Cited by 103
Therapeutic potential of anti-oxidants and diabetic retinopathy
Kowluru, R. A., & Kennedy, A. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.9.1665 · Cited by 100
The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens
Kinoshita, J. H., Dvornik, D., Kramil, M., et al. (1968) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(68)90305-x · Cited by 100
THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX
Borhani, D. W., Harter, T. M., & Petrash, J. M. (1992) · Worldwide Protein Data Bank · doi:10.2210/pdb1abn/pdb · Cited by 99
Kinetic and Structural Characterization of the Glutathione-binding Site of Aldose Reductase
Dixit, B. L., Balendiran, G. K., Watowich, S. J., Srivastava, S., Ramana, K. V., Petrash, J. M., Bhatnagar, A., & Sk, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909235199 · Cited by 96
Self-citationSong, Z. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00096-4 · Cited by 95
Ramana, K. V., Friedrich, B. M., Bhatnagar, A., & Sk, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0568fje · Cited by 94
Self-citationThe crystal structure of the aldose reductase.NADPH binary complex.
Borhani, D. W., Harter, T. M., & Petrash, J. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35840-x · Cited by 92
Ruef, J., Liu, S.-Q., Bode, C., Tocchi, M., Srivastava, S., Runge, M. S., & Bhatnagar, A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1745 · Cited by 89
Self-citationPrevention of Sugar-Induced Cataractogenesis in Rats by Butylated Hydroxytoluene
Sk, S., & Ansari, N. H. (1988) · Diabetes · doi:10.2337/diab.37.11.1505 · Cited by 88
Selective Recognition of Glutathiolated Aldehydes by Aldose Reductase
Ramana, K. V., Dixit, B. L., Srivastava, S., Balendiran, G. K., Sk, S., & Bhatnagar, A. (2000) · Biochemistry · doi:10.1021/bi000796e · Cited by 87
Self-citationClinical Trial of an Aldose Reductase Inhibitor in Diabetic Neuropathy
Handelsman, D. J., & Turtle, J. R. (1981) · Diabetes · doi:10.2337/diab.30.6.459 · Cited by 87
Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells
Ramana, K. V., Chandra, D., Srivastava, S., Bhatnagar, A., & Sk, S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0722com · Cited by 85
Self-citationRamana, K. V., Bhatnagar, A., & Sk, S. (2004) · The FASEB Journal · doi:10.1096/fj.04-1650com · Cited by 85
Self-citationTuttle, K. R., & Anderson, P. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00741-8 · Cited by 85
Inhibitors of Protein Kinase C (PKC) Prevent Activated Transcription
Catley, M. C., Cambridge, L. M., Nasuhara, Y., Ito, K., Chivers, J. E., Beaton, A., Holden, N. S., Bergmann, M. W., Barnes, P. J., & Newton, R. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400765200 · Cited by 83
Role of aldose reductase and sorbitol in maintaining the medullary intracellular milieu
Burg, M. B. (1988) · Kidney International · doi:10.1038/ki.1988.46 · Cited by 80
Neurovascular disease, antioxidants and glycation in diabetes
Dickinson, P. J., Carrington, A. L., Frost, G. S., & Boulton, A. J. M. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.305 · Cited by 80
Nitric Oxide Prevents Aldose Reductase Activation and Sorbitol Accumulation During Diabetes
Chandra, D., Jackson, E. B., Ramana, K. V., Kelley, R., Sk, S., & Bhatnagar, A. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3095 · Cited by 79
Self-citationMorgan, K. P., Kapur, A., & Beatt, K. J. (2004) · Heart · doi:10.1136/hrt.2003.021014 · Cited by 78
Srivastava, S., Chandra, A., Ansari, H., SRIVASTAVA, K. S., & Bhatnagar, A. (1998) · Biochemical Journal · doi:10.1042/bj3290469 · Cited by 75
Self-citationPassariello, N., Sepe, J. J., Marrazzo, G., Cicco, A. D., Peluso, A., Plsano, M., Sgambato, S., Tesauro, P., & D'Onofrio, F. (1993) · Diabetes Care · doi:10.2337/diacare.16.5.789 · Cited by 73
Srivastava, S. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00454-3 · Cited by 69
Self-citationSequence analysis of bovine lens aldose reductase.
Schade, S. Z., Early, S. L., Williams, T. R., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39639-5 · Cited by 68
O'Connor, T., Ireland, L. S., Harrison, D. J., et al. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430487 · Cited by 66
Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids
Srivastava, S., Spite, M. R., Trent, J. O., West, M., Ahmed, Y., & Bhatnagar, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403416200 · Cited by 65
Self-citationIntracellular mechanism of highd-glucose-induced modulation of vascular cell proliferation
Graier, W. F., Grubenthal, I., Dittrich, P., Wascher, T. C., & Kostner, G. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00534-x · Cited by 60
Galactosemic Neuropathy in Transgenic Mice for Human Aldose Reductase
Yagihashi, S., Yamagishi, S., Wada, R., Sugimoto, K., Baba, M., Wong, H.-G., Fujimoto, J., Nishimura, C., & Kokai, Y. (1996) · Diabetes · doi:10.2337/diab.45.1.56 · Cited by 58
Site-Specific Inactivation of Aldose Reductase by 4-Hydroxynonenal
CORSO, A. D., Monte, M. D., Vilardo, P. G., Cecconi, I., Moschini, R., Banditelli, S., Cappiello, M., Tsai, L., & Mura, U. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0488 · Cited by 55
Diabetes-Induced Changes in Retinal NAD-Redox Status
Obrosova, I. G., Stevens, M. J., & Lang, H.-J. (2001) · Pharmacology · doi:10.1159/000056091 · Cited by 55
Boon, P. J. M., Marinho, H. S., Oosting, R., & Mulder, G. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8742 · Cited by 51
Foey, A., & Brennan, F. M. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01852.x · Cited by 47
Aldose Reductase Inhibitors: An Update
Tsai, S. C., & Burnakis, T. G. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700616 · Cited by 46
Endothelial dysfunction and hypertension in diabetes mellitus
Dandona, P., Chaudhuri, A., & Aljada, A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.006 · Cited by 42
Structural and kinetic modifications of aldose reductase by S-nitrosothiols
Srivastava, S., Dixit, B. L., Ramana, K. V., Chandra, D., CHANDRA, D., Zacarias, A., Petrash, J. M., Bhatnagar, A., & Sk, S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580111 · Cited by 35
Self-citationThomas, T., Porcellati, F., Kato, K., Stevens, M. J., Sherman, W. R., & Greene, D. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117286 · Cited by 33
Ischemic heart disease and congestive heart failure in diabetic patients
Tang, W. H. W., Maroo, A. P., & Young, J. B. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.008 · Cited by 31
Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis
Ansari, N. H., & Srivastava, S. K. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91119-d · Cited by 29
Self-citationWILMER, L., JR, S., MILLS, R., Bigler, C. F., Eaton, R. P., Griffey, R. H., & VANDERJAGT, D. (1989) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(89)90038-9 · Cited by 28
Characterization of the glutathione binding site of aldose reductase
Ramana, K. V., Dixit, B. L., Srivastava, S., Bhatnagar, A., Balendiran, G. K., Watowich, S. J., Petrash, J. M., & Sk, S. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00297-0 · Cited by 27
Self-citationTrolox protects hyperglycemia-induced cataractogenesis in cultured rat lens.
Ansari, N. H., Bhatnagar, A., Fulep, E. E., et al. (1994) · PubMed · Cited by 26
Self-citationHyperglycemic cytosolic reductive stress 'pseudohypoxia': implications for diabetic retinopathy.
Ido, Y., & Williamson, J. R. (1997) · PubMed · Cited by 25
Active site modification of aldose reductase by nitric oxide donors
Chandra, A., Srivastava, S., Petrash, J. M., Bhatnagar, A., & Sk, S. (1997) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00084-8 · Cited by 25
Self-citationIron overload and gene expression in HepG2 cells: analysis by differential display
Barisani, D., Meneveri, R., Ginelli, E., Cassani, C., & Conte, D. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01280-1 · Cited by 24
Shimizu, H., Ohtani, K., Tsuchiya, T., Sato, N., Tanaka, Y., Takahashi, H., Uehara, Y., Inukai, T., & Mori, M. (2000) · PubMed · Cited by 23
Ranganathan, S., Krempf, M., Féraille, E., & Charbonnel, B. H. (1993) · PubMed · Cited by 23
RICHER, S. P. (2000) · International Ophthalmology Clinics · doi:10.1097/00004397-200010000-00002 · Cited by 21
Tawata, M., Ohtaka, M., Hosaka, Y., & Onaya, T. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90480-d · Cited by 20
Aldose reductase inhibitors as pathobiochemical probes
Dvornik, D. (1992) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(92)90045-m · Cited by 15
Increased white cell aldose reductase mRNA levels in diabetic patients
Kicic, E., & Palmer, T. N. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01265-x · Cited by 6
Bhatnagar, A., Srivastava, S., Wang, L., Chandra, A., Ansari, N. H., & Sk, S. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4735-8_27 · Cited by 4
Self-citationSpallarossa, P., Barsotti, A., Cordera, R., Ghigliotti, G., Maggi, D. C., & Brunelli, C. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345297 · Cited by 4
Cited by
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Oxidative stress, insulin signaling, and diabetes
Rains, J. L., & Jain, S. K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.006 · Cited by 1,435
Kolluru, G. K., Bir, S. C., & Kevil, C. G. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/918267 · Cited by 720
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
Protein S-glutathionylation: a regulatory device from bacteria to humans
Dalle-Donne, I., Rossi, R., Colombo, G., Giustarini, D., & Milzani, A. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.11.002 · Cited by 628
Metadata
- Authors
- Srivastava, S. K., Ramana, K. V., & Bhatnagar, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-04-06
- Volume
- 26
- Issue
- 3
- Pages
- 380-392
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2028644941
- Cited by
- 527
- References
- 97
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.